Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach
Abstract
Keywords
References
- 1. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021; 134(7):783-91.
- 2. Choudhury H, Maheshwari R, Pandey M, Tekade M, Gorain B, Tekade RK. Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug 'Etoposide'. Mater Sci Eng C Mater Biol Appl. 2020; 106:110275.
- 3. Semis HS, Kandemir FM, Kaynar O, Dogan T, Arikan SM. The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats. Life Sci. 2021; 287:120104.
- 4. Galley HF, McCormick B, Wilson KL, Lowes DA, Colvin L, Torsney C. Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat. J Pineal Res. 2017; 63(4):e12444.
- 5. Yardım A, Kandemir FM, Çomaklı S, et al. Protective Effects of Curcumin Against Paclitaxel-Induced Spinal Cord and Sciatic Nerve Injuries in Rats. Neurochem Res. 2021; 46(2):379-95.
- 6. Yang YH, Mao JW, Tan XL. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel. Chin J Nat Med. 2020; 18(12):890-97.
- 7. Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019; 24:40.
- 8. Klein I, Lehmann HC. Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy. Toxics. 2021; 9(10):229.
Details
Primary Language
English
Subjects
Biochemistry and Cell Biology (Other)
Journal Section
Research Article
Authors
Selçuk Yılmaz
*
0000-0003-2508-8558
Türkiye
Hasan Şimşek
0000-0001-5573-4923
Türkiye
Sefa Küçükler
0000-0002-8222-5515
Türkiye
Serpil Aygörmez
0000-0002-5675-5096
Türkiye
Ender Erdoğan
0000-0003-4360-6013
Türkiye
Publication Date
September 21, 2023
Submission Date
July 10, 2023
Acceptance Date
August 12, 2023
Published in Issue
Year 2023 Volume: 4 Number: 3
